Apparently low reproducibility of true differential expression discoveries in microarray studies

Bioinformatics

Volumn 24, Issue 18, 2008, Pages 2057-2063

  Zhang, Min ^a   Yao, Chen ^b   Guo, Zheng ^a,b   Zou, Jinfeng ^a   Zhang, Lin ^b   Xiao, Hui ^a   Wang, Dong ^a   Yang, Da ^a   Gong, Xue ^a   Zhu, Jing ^b   Li, Yanhui ^b   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; LIVER CARCINOMA; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; REPRODUCIBILITY; SIMULATION; STATISTICAL MODEL;

EID: 51749123784     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btn365     Document Type: Article

References (50)

1. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B Met., 57, 289-300.
2. Broadhurst,D.I. and Kell,D.B. (2006) Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171-196.
3. Chen,J. et al. (2007) Reproducibility of microarray data: A further analysis of microarray quality control (MAQC) data. BMC Bioinformatics, 8, 412.
4. Chen,X. et al. (2002) Gene expression patterns in human liver cancers. Mol. Biol. Cell, 13, 1929-1939.
5. Diehn,M. et al. (2003) SOURCE: A unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res., 31, 219-223.
6. Do,J.H. and Choi,D.K. (2006) Normalization of microarray data: single-labeled and dual-labeled arrays. Mol. Cells, 22, 254-261.
7. Dobbin,K.K. et al. (2005) Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin. Cancer Res., 11, 565-572.
8. Ein-Dor,L. et al. (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics, 21, 171-178.
9. Ein-Dor,L. et al. (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc. Natl Acad. Sci. USA, 103, 5923-5928.
10. Frantz,S. (2005) An array of problems. Nat. Rev. Drug Discov., 4, 362-363.
11. Gautier,L. et al. (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-315.
12. Guo,L. et al. (2006) Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat. Biotechnol., 24 1162-1169.
13. Guo,Z. et al. (2007) Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network. Bioinformatics, 23, 2121-2128.
14. Guo,Z. et al. (2005) Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics, 6, 58.
15. Hakes,L. et al. (2008) Protein-protein interaction networks and biology-what's the connection? Nat. Biotechnol., 26, 69-72.
16. Hosack,D.A. et al. (2003) Identifying biological themes within lists of genes with EASE. Genome Biol., 4, R70.
17. Irizarry,R.A. et al. (2005) Multiple-laboratory comparison of microarray platforms. Nat. Methods, 2, 345-350.
18. Klebanov,L. et al. (2006) A new type of stochastic dependence revealed in gene expression data. Stat. Appl. Genet. Mol. Biol., 5, Article7.
19. Klebanov,L. et al. (2007) Statistical methods and microarray data. Nat. Biotechnol., 25, 25-26; author reply 26-27.
20. Klebanov,L. and Yakovlev,A. (2007) How high is the level of technical noise in microarray data? Biol. Direct, 2, 9.
21. Lander,E.S. (1999) Array of hope. Nat. Genet., 21, 3-4.
22. Lapointe,J. et al. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl Acad. Sci. USA, 101, 811-816.
23. Li,X. et al. (2004) Gene mining: A novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling. Nucleic Acids Res., 32, 2685-2694.
24. Marshall,E. (2004) Getting the noise out of gene arrays. Science, 306, 630-631.
25. Miklos,G.L. and Maleszka,R. (2004) Microarray reality checks in the context of a complex disease. Nat. Biotechnol., 22, 615-621.
26. Pavlidis,P. et al. (2003) The effect of replication on gene expression microarray experiments. Bioinformatics, 19, 1620-1627.
27. Pawitan,Y. et al. (2005a) False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics, 21, 3017-3024.
28. Pawitan,Y. et al. (2005b) Bias in the estimation of false discovery rate in microarray studies. Bioinformatics, 21, 3865-3872.
29. Perelman,E. et al. (2007) Detecting differential expression in microarray data: Comparison of optimal procedures. BMC Bioinformatics 8, 28.
30. Qiu,X. et al. (2006) Assessing stability of gene selection in microarray data analysis. BMC Bioinformatics, 7, 50.
31. Quackenbush,J. (2002) Microarray data normalization and transformation. Nat. Genet., 32 (Suppl.), 496-501.
32. Ransohoff,D.F. (2004) Rules of evidence for cancer molecular-marker discovery and validation. Nat. Rev. Cancer, 4, 309-314.
33. Ransohoff,D.F. (2005a) Bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer, 5, 142-149.
34. Ransohoff,D.F. (2005b) Lessons from controversy: Ovarian cancer screening and serum proteomics. J. Natl Cancer Inst., 97, 315-319.
35. Rhodes,D.R. et al. (2007) Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia, 9, 166-180.
36. Shi,L. et al. (2005) Cross-platform comparability of microarray technology: Intraplatform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics, 6 (Suppl. 2), S12.
37. Shi,L. et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol., 24, 1151-1161.
38. Subramanian,A. et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
39. Tan,P.K. et al. (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res., 31 5676-5684.
40. Tong,W. et al. (2006) Evaluation of external RNA controls for the assessment of microarray performance. Nat. Biotechnol., 24, 1132-1139.
41. Troyanskaya,O. et al. (2001) Missing value estimation methods for DNA microarrays. Bioinformatics, 17, 520-525.
42. Tusher,V.G. et al. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA 98, 5116-5121.
43. Xie,Y. et al. (2005) A note on using permutation-based false discovery rate estimates to compare different analysis methods for microarray data. Bioinformatics, 21, 4280-4288.
44. Xu,J.Z. et al. (2006) Peeling off the hidden genetic heterogeneities of cancers based on disease-relevant functional modules. Mol. Med., 12, 25-33.
45. Xu,R. and Li,X. (2003) A comparison of parametric versus permutation methods with applications to general and temporal microarray gene expression data. Bioinformatics, 19, 1284-1289.
46. Yang,D. et al. (2008) Gaining confidence in biological interpretation of the microarray data: The functional consistence of the significant GO categories. Bioinformatics, 24, 265-271.
47. Yang,Y.H. et al. (2002) Normalization for cDNA microarray data: A robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res., 30, e15.
48. Yeoh,E.J. et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 1, 133-143.
49. Zhang,S. (2007) A comprehensive evaluation of SAM, the SAM R-package and a simple modification to improve its performance. BMC Bioinformatics 8, 230.
50. Zhu,J. et al. (2007) GO-2D: Identifying 2-dimensional cellular-localized functional modules in Gene Ontology. BMC Genomics 8, 30.